£179.96

Springer Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)

Price data last checked 134 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£180 today · usual range £0–£0 · best ever £169

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 597 days • 597 data points (No recent data available)

Historical
Generating forecast...
£179.99 £167.87 £170.51 £173.16 £175.80 £178.45 £181.09 10 June 2024 06 November 2024 04 April 2025 31 August 2025 27 January 2026

Price Distribution

Price distribution over 597 days • 4 price levels

Days at Price
Current Price
50 days 21 days 452 days 74 days · current 0 113 226 339 452 £169 £178 £179 £180 Days at Price

Price Analysis

Most common price: £179 (452 days, 75.7%)

Price range: £169 - £180

Price levels: 4 different prices over 597 days

Description

Relapse of leukemia following successful remission-induction therapy remains a major obstacle in the treatment of patients with acute leukemia. Leukemia recurs most frequently in patients with acute myeloblastic leukemia (AML) and high risk acute lymphoblastic leukemia (ALL) following chemotherapy and less often in patients with low risk ALL and particularly in patient groups> submitted to allogeneic marrow transplantation. ' It is likely that the great majority of these recurrences originate from residual leukemic cells that survive initial remission-induction chemotherapy. Today, several research groups throughout the world place emphasis on studies concerned with the detection and treatment of 'minimal residual disease' (MRD). These investigations are conducted with the common objective to tackle the remaining cells. 'Minimal Residual Disease in Acute Leukemia: 1986' summarizes the fast advancements in this area. Several disciplines are concerned with the analysis of leukemic cells. The perspectives of cytogenetic and molecular genetic approaches for applica tion in the detection of MRD are reviewed. In this respect, modern cyto genetics provide highly specific tumor markers. The resolution of cyto genetic methods can be particularly improved when combined with other techniques which select relevant subpopulations of cells. Characterization of oncogenes and gene rearrangements, including those of immunoglobulin and T-cell receptor genes, and the measurement of gene products, have been established. Techniques based on these approaches offer interesting tools for the detection of MRD. New possibilities of employing monoclonal anti bodies are also presented.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 March 1986
Listed Since
23 January 2007

Barcode

No barcode data available

Similar Products You Might Like

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)
98% match

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)

Springer

£110.29 12 Dec 2025
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
97% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£96.51 12 Apr 2026
Springer Hematologic Cancers: Molecular Pathobiology to Therapy
97% match

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Springer

£113.48 20 Apr 2026
Humana Leukemia: Methods and Protocols: 538 (Molecular Biology)
97% match

Humana Leukemia: Methods and Protocols: 538 (Molecular Biology)

Humana

£102.16 19 Apr 2026
CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)
97% match

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

£113.67 09 Jan 2026
Chemotherapy for Leukemia: Novel Drugs and Treatment
97% match

Chemotherapy for Leukemia: Novel Drugs and Treatment

Springer

£105.45 09 Mar 2026
Acute Myelogenous Leukemia (Contemporary Hematology)
97% match

Acute Myelogenous Leukemia (Contemporary Hematology)

Humana

£164.16 09 Jan 2026
Acute Myeloid Leukemia (Hematologic Malignancies)
97% match

Acute Myeloid Leukemia (Hematologic Malignancies)

£92.25 08 Jan 2026
Etiology of Acute Leukemias in Children
97% match

Etiology of Acute Leukemias in Children

Springer

£116.55 10 Apr 2026
Acute Leukemias (Hematologic Malignancies)
97% match

Acute Leukemias (Hematologic Malignancies)

Springer

£103.69 12 Jan 2026
Leukemias
97% match

Leukemias

Springer

£76.02 18 Apr 2026
The Genetic Basis of Haematological Cancers
97% match

The Genetic Basis of Haematological Cancers

Wiley

£102.65 09 Jan 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
97% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

£116.62 13 Jan 2026
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
97% match

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

CRC Press

£147.25 13 Apr 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
97% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Springer

£122.70 07 Mar 2026
Consulting Hematology and Oncology Handbook
97% match

Consulting Hematology and Oncology Handbook

Springer

£57.66 08 Mar 2026
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
97% match

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Springer

£92.42 08 Jan 2026
Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)
97% match

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Humana

£84.99 17 Mar 2026
Leukemia Stem Cells in Hematologic Malignancies: 1143 (Advances in Experimental Medicine and Biology, 1143)
97% match

Leukemia Stem Cells in Hematologic Malignancies: 1143 (Advances in Experimental Medicine and Biology, 1143)

Springer

£103.97 07 Mar 2026
MYELODYSPLASTIC SYNDROMES: From Pathogenesis to Diagnosis & Therapy (Recent Advances in Hematology Research)
97% match

MYELODYSPLASTIC SYNDROMES: From Pathogenesis to Diagnosis & Therapy (Recent Advances in Hematology Research)

£104.18 13 Jan 2026
Molecular Hematopathology: An Integrated Case-Based Approach
97% match

Molecular Hematopathology: An Integrated Case-Based Approach

£145.94 26 Jan 2026
Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)
97% match

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)

Elsevier

£71.63 27 Feb 2026
Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)
97% match

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Springer

£149.65 14 Apr 2026
Myelodysplastic Syndromes: Pathobiology and Clinical Management: 36 (Basic and Clinical Oncology)
97% match

Myelodysplastic Syndromes: Pathobiology and Clinical Management: 36 (Basic and Clinical Oncology)

CRC Press

£142.02 02 Mar 2026